Cargando…

Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model

Purpose. To study factors affecting patients' compliance to antiglaucoma medications in Egypt where there are unique factors as a developing country. Patients and Methods. A cross-sectional descriptive study on 440 Egyptian patients with open angle glaucoma (OAG) recruited for over two years. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu Hussein, Nahla B., Eissa, Iman M., Abdel-Kader, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488247/
https://www.ncbi.nlm.nih.gov/pubmed/26167292
http://dx.doi.org/10.1155/2015/234157
_version_ 1782379116307152896
author Abu Hussein, Nahla B.
Eissa, Iman M.
Abdel-Kader, Ahmed A.
author_facet Abu Hussein, Nahla B.
Eissa, Iman M.
Abdel-Kader, Ahmed A.
author_sort Abu Hussein, Nahla B.
collection PubMed
description Purpose. To study factors affecting patients' compliance to antiglaucoma medications in Egypt where there are unique factors as a developing country. Patients and Methods. A cross-sectional descriptive study on 440 Egyptian patients with open angle glaucoma (OAG) recruited for over two years. The patients were thoroughly interviewed about their age, education level, duration of glaucoma, difficulty in instilling the drops, medication regimens, a family history of glaucoma, knowledge of the disease, and the presence of medical insurance. Results. 236 (53.6%) were noncompliant compared to 204 (46.4%) who were compliant. Females had a tendency for higher compliance (p=0.061). Patient age above 50 years and low level of education and negative family history of glaucoma were factors significantly associated with poor compliance (p < 0.0001). Polytherapy and lack of medical insurance could be contributing factors. Conclusion. Egyptian patients have a high rate of noncompliance compared to the average in literature. Great effort is needed in educating patients about the importance of medications and the risk and the prognosis of this disease. Economic factors must also be taken into consideration in developing countries with large number of poor patients. We recommend simplifying drug regimens, incorporating electronic dose monitors, and creating reminders for follow-up visits of glaucoma patients.
format Online
Article
Text
id pubmed-4488247
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-44882472015-07-12 Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model Abu Hussein, Nahla B. Eissa, Iman M. Abdel-Kader, Ahmed A. J Ophthalmol Research Article Purpose. To study factors affecting patients' compliance to antiglaucoma medications in Egypt where there are unique factors as a developing country. Patients and Methods. A cross-sectional descriptive study on 440 Egyptian patients with open angle glaucoma (OAG) recruited for over two years. The patients were thoroughly interviewed about their age, education level, duration of glaucoma, difficulty in instilling the drops, medication regimens, a family history of glaucoma, knowledge of the disease, and the presence of medical insurance. Results. 236 (53.6%) were noncompliant compared to 204 (46.4%) who were compliant. Females had a tendency for higher compliance (p=0.061). Patient age above 50 years and low level of education and negative family history of glaucoma were factors significantly associated with poor compliance (p < 0.0001). Polytherapy and lack of medical insurance could be contributing factors. Conclusion. Egyptian patients have a high rate of noncompliance compared to the average in literature. Great effort is needed in educating patients about the importance of medications and the risk and the prognosis of this disease. Economic factors must also be taken into consideration in developing countries with large number of poor patients. We recommend simplifying drug regimens, incorporating electronic dose monitors, and creating reminders for follow-up visits of glaucoma patients. Hindawi Publishing Corporation 2015 2015-06-17 /pmc/articles/PMC4488247/ /pubmed/26167292 http://dx.doi.org/10.1155/2015/234157 Text en Copyright © 2015 Nahla B. Abu Hussein et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Abu Hussein, Nahla B.
Eissa, Iman M.
Abdel-Kader, Ahmed A.
Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model
title Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model
title_full Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model
title_fullStr Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model
title_full_unstemmed Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model
title_short Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model
title_sort analysis of factors affecting patients' compliance to topical antiglaucoma medications in egypt as a developing country model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488247/
https://www.ncbi.nlm.nih.gov/pubmed/26167292
http://dx.doi.org/10.1155/2015/234157
work_keys_str_mv AT abuhusseinnahlab analysisoffactorsaffectingpatientscompliancetotopicalantiglaucomamedicationsinegyptasadevelopingcountrymodel
AT eissaimanm analysisoffactorsaffectingpatientscompliancetotopicalantiglaucomamedicationsinegyptasadevelopingcountrymodel
AT abdelkaderahmeda analysisoffactorsaffectingpatientscompliancetotopicalantiglaucomamedicationsinegyptasadevelopingcountrymodel